Application Nr Approved Date Route Status External Links
ANDA076015 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Fluoxetine Is Indicated For The Treatment Of: Acute And Maintenance Treatment Of Major Depressive Disorder [ See Clinical Studies (14.1) ]. Acute And Maintenance Treatment Of Obsessions And Compulsions In Patients With Obsessive Compulsive Disorder (Ocd) [ See Clinical Studies (14.2) ]. Acute And Maintenance Treatment Of Binge-Eating And Vomiting Behaviors In Patients With Moderate To Severe Bulimia Nervosa [ See Clinical Studies (14.3) ]. Acute Treatment Of Panic Disorder, With Or Without Agoraphobia [ See Clinical Studies (14.4) ]. Fluoxetine Monotherapy Is Not Indicated For The Treatment Of Depressive Episodes Associated With Bipolar I Disorder Or The Treatment Of Treatment Resistant Depression. Fluoxetine Is A Selective Serotonin Reuptake Inhibitor Indicated For: Acute And Maintenance Treatment Of Major Depressive Disorder (Mdd) ( 1 ) Acute And Maintenance Treatment Of Obsessive Compulsive Disorder (Ocd) ( 1 ) Acute And Maintenance Treatment Of Bulimia Nervosa ( 1 ) Acute Treatment Of Panic Disorder, With Or Without Agoraphobia ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Fluoxetine Hydrochloride FLUOXETINE HYDROCHLORIDE ZINC1530637

Comments